Transposon Therapeutics, Inc. Science Pipeline Team News / Literature Connect
Mark Mugerditchian

Mark Mugerditchian

VP Manufacturing

Mark has > 42 years CMC experience. His broad technical background covers several formats of drug substance (small molecule synthesis and biotechnology) and drug product (SVP, LVP, Solid Oral Dose, inhalation, transdermal, diagnostic). Recent posts include PvP Biologics, Laguna Pharmaceuticals, Sequel, NovaMedica and NovaCardia.